We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

78 hedge funds and large institutions have $71.9M invested in abrdn Life Sciences Investors in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 20

0.01% more ownership

Funds ownership: 20.75% → 20.76% (+0.01%)

3% less capital invested

Capital invested by funds: $73.9M → $71.9M (-$2.07M)

3% less funds holding

Funds holding: 80 → 78 (-2)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

Holders
78
Holders Change
-2
Holders Change %
-2.5%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
32
Reduced
20
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$1.24M
2
1CP
1607 Capital Partners
Virginia
+$1.06M
3
Allspring Global Investments
Allspring Global Investments
North Carolina
+$897K
4
RJA
Raymond James & Associates
Florida
+$782K
5
AA
AQR Arbitrage
Connecticut
+$572K

Top Sellers

1
Wells Fargo
Wells Fargo
California
-$2.27M
2
AAM
Advisors Asset Management
Colorado
-$1.22M
3
Bank of America
Bank of America
North Carolina
-$784K
4
Millennium Management
Millennium Management
New York
-$702K
5
WAM
Weiss Asset Management
Massachusetts
-$403K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$7.39M +$1.24M +86,482 +19%
1CP
2
1607 Capital Partners
Virginia
$6.46M +$1.06M +73,984 +19%
FHA
3
Flagship Harbor Advisors
Massachusetts
$5.11M -$5.23K -366 -0.1%
RJA
4
Raymond James & Associates
Florida
$4.32M +$782K +54,721 +21%
WAM
5
Wolverine Asset Management
Illinois
$4.27M +$512K +35,802 +13%
NIM
6
Needham Investment Management
New York
$4.17M – – –
CA
7
Cornerstone Advisors
North Carolina
$3.51M +$24.3K +1,700 +0.7%
Allspring Global Investments
8
Allspring Global Investments
North Carolina
$3.05M +$897K +62,721 +40%
Lazard Asset Management
9
Lazard Asset Management
New York
$2.58M – – –
LPL Financial
10
LPL Financial
California
$2.33M +$81.8K +5,723 +4%
LSC
11
Logan Stone Capital
Illinois
$2.13M -$86.9K -6,081 -4%
Ameriprise
12
Ameriprise
Minnesota
$1.89M +$217K +15,196 +13%
Wells Fargo
13
Wells Fargo
California
$1.74M -$2.27M -158,468 -56%
1WA
14
180 Wealth Advisors
Washington
$1.56M +$34.3K +2,398 +2%
AAM
15
Advisors Asset Management
Colorado
$1.49M -$1.22M -85,328 -44%
AA
16
AQR Arbitrage
Connecticut
$1.31M +$572K +39,988 +74%
Bank of America
17
Bank of America
North Carolina
$1.3M -$784K -54,812 -37%
Cetera Investment Advisers
18
Cetera Investment Advisers
Illinois
$1.29M +$188K +13,123 +16%
Cohen & Steers
19
Cohen & Steers
New York
$1.16M – – –
Osaic Holdings
20
Osaic Holdings
Arizona
$1.04M +$57K +3,986 +6%
Janney Montgomery Scott
21
Janney Montgomery Scott
Pennsylvania
$934K +$99.4K +6,954 +12%
RJFSA
22
Raymond James Financial Services Advisors
Florida
$929K +$45K +3,146 +5%
SFS
23
Shaker Financial Services
Virginia
$927K +$21.4K +1,500 +2%
Stifel Financial
24
Stifel Financial
Missouri
$814K -$261K -18,288 -24%
Walleye Capital
25
Walleye Capital
New York
$784K +$120K +8,362 +17%
1
2 3 4

HQL Hedge Fund Activity: Q1 2023 in Review

78 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2023, worth a combined $71.9M — down 2.8% from $73.9M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of HQL and 8 opened new positions — a net loss of 1 holder — while 20 trimmed existing stakes and 32 added.

The largest buyer was Morgan Stanley, adding an estimated $1.24M. The largest seller was Wells Fargo, cutting an estimated $2.27M.

  • 78 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2023, down from 80 in Q4 2022.
  • Funds reported $71.9M of abrdn Life Sciences Investors stock for Q1 2023, down 2.8% quarter-over-quarter.
  • 8 funds opened new abrdn Life Sciences Investors positions in Q1 2023 and 9 closed out, a net change of -1 holder.
  • The largest abrdn Life Sciences Investors buyer in Q1 2023 was Morgan Stanley, an estimated $1.24M added.
  • The largest abrdn Life Sciences Investors seller in Q1 2023 was Wells Fargo, an estimated $2.27M sold.

Based on aggregated 13F filings for Q1 2023.